Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Simon N Pimstone Insider Profile
11 Followers
Simon N Pimstone, Chairman at Xenon, holds 22.46K shares in Xenon (Ticker: XENE), holds 8.63K shares in Eupraxia Pharmaceuticals (Ticker: TSE:EPRX). Most recently, Simon N Pimstone ― shares of Xenon on ― for an estimated value of ―.
Simon N Pimstone has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Simon N Pimstone holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Simon N Pimstone
Simon N Pimstone's Trading History
Xenon
―
Chairman
―
$922.88K
Eupraxia Pharmaceuticals
Aug 21, 2023
Director
Informative Buy
28.00K
C$34.16K
List of latest transactions for each holding click on a transaction to see Simon N Pimstone's performance on stock
You May Also Like
Simon N Pimstone insider profile FAQ
What is the percentage of profitable transactions made by Simon N Pimstone?
The percentage of profitable transactions made by Simon N Pimstone is ―.
What is the average return per transaction made by Simon N Pimstone?
The average return per transaction made by Simon N Pimstone is ―.
What stocks does Simon N Pimstone hold?
Simon N Pimstone holds: XENE, TSE:EPRX stocks.
What was Simon N Pimstone’s latest transaction?
Simon N Pimstone latest transaction was an Uninformative Buy of ―.
What was Simon N Pimstone's most profitable transaction?
Simon N Pimstone’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Simon N Pimstone's role in Xenon?
Simon N Pimstone's role in Xenon is Chairman.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.